Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Securin predicts aneuploidy and survival in breast cancer.

Karra H, Pitkänen R, Nykänen M, Talvinen K, Kuopio T, Söderström M, Kronqvist P.

Histopathology. 2012 Mar;60(4):586-96. doi: 10.1111/j.1365-2559.2011.04107.x. Epub 2012 Jan 19.

PMID:
22260438
2.

Low cdc27 and high securin expression predict short survival for breast cancer patients.

Talvinen K, Karra H, Pitkänen R, Ahonen I, Nykänen M, Lintunen M, Söderström M, Kuopio T, Kronqvist P.

APMIS. 2013 Oct;121(10):945-53. doi: 10.1111/apm.12110. Epub 2013 Jun 12.

PMID:
23755904
3.

Securin promotes the identification of favourable outcome in invasive breast cancer.

Talvinen K, Karra H, Hurme S, Nykänen M, Nieminen A, Anttinen J, Kuopio T, Kronqvist P.

Br J Cancer. 2009 Sep 15;101(6):1005-10. doi: 10.1038/sj.bjc.6605237. Epub 2009 Aug 18.

4.

Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer.

Talvinen K, Tuikkala J, Nevalainen O, Rantanen A, Hirsimäki P, Sundström J, Kronqvist P.

Br J Cancer. 2008 Jul 22;99(2):335-40. doi: 10.1038/sj.bjc.6604475. Epub 2008 Jul 1.

5.

Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma.

Winnepenninckx V, Debiec-Rychter M, Beliën JA, Fiten P, Michiels S, Lazar V, Opdenakker G, Meijer GA, Spatz A, van den Oord JJ.

Mod Pathol. 2006 Sep;19(9):1170-80. Epub 2006 Jun 23.

6.

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.

Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT.

Cancer. 1996 Feb 15;77(4):697-709.

7.

Prognostic implications of securin expression and sub-cellular localization in human breast cancer.

Gurvits N, Repo H, Löyttyniemi E, Nykänen M, Anttinen J, Kuopio T, Talvinen K, Kronqvist P.

Cell Oncol (Dordr). 2016 Aug;39(4):319-31. doi: 10.1007/s13402-016-0277-5. Epub 2016 Mar 16.

PMID:
26984614
8.

Cdc20 and securin overexpression predict short-term breast cancer survival.

Karra H, Repo H, Ahonen I, Löyttyniemi E, Pitkänen R, Lintunen M, Kuopio T, Söderström M, Kronqvist P.

Br J Cancer. 2014 Jun 10;110(12):2905-13. doi: 10.1038/bjc.2014.252. Epub 2014 May 22.

9.

Securin is overexpressed in breast cancer.

Ogbagabriel S, Fernando M, Waldman FM, Bose S, Heaney AP.

Mod Pathol. 2005 Jul;18(7):985-90.

10.

Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?

Keyhani-Rofagha S, O'Toole RV, Farrar WB, Sickle-Santanello B, DeCenzo J, Young D.

Cancer. 1990 Apr 1;65(7):1577-82.

11.

Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.

Gong YP, Yarrow PM, Carmalt HL, Kwun SY, Kennedy CW, Lin BP, Xing PX, Gillett DJ.

Eur J Surg Oncol. 2007 May;33(4):438-43. Epub 2006 Nov 27.

PMID:
17125961
12.
13.

[Prognostic significance of cellular DNA ploidy level of the breast cancer].

Li JY.

Zhonghua Wai Ke Za Zhi. 1992 Jan;30(1):35-7, 63. Chinese.

PMID:
1499424
14.

Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.

Owainati AA, Robins RA, Hinton C, Ellis IO, Dowle CS, Ferry B, Elston CW, Blamey RW, Baldwin RW.

Br J Cancer. 1987 Apr;55(4):449-54.

15.

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.

Jansen RL, Joosten-Achjanie SR, Volovics A, Arends JW, Hupperets PS, Hillen HF, Schouten HC.

Anticancer Res. 1998 Nov-Dec;18(6A):4455-62.

PMID:
9891509
16.

Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.

Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bànkfalvi A, Kneif S, Torhorst J, Zuber M, Köchli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F, Boecker W.

J Pathol. 2002 Oct;198(2):181-9.

PMID:
12237877
17.
19.

The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.

Wong SW, Rangan AM, Bilous AM, Boyages J, Gebski V, Benson EM.

Pathology. 1999 May;31(2):90-4.

PMID:
10399161
20.

Supplemental Content

Support Center